Clinical Trials Browser

Phase 2 × Neurodegenerative Diseases × 90 days × Clear all

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Neurocognitive Disorders, Tauopathies

Clinical Trials

An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease